Spontaneous nasal perforation in a bevacizumab-treated patient with metastatic breast cancer

被引：4
|
作者：
Rodriguez, Cesar A. [1 ]
Martin, Teresa [1 ]
Lozano, Rebeca [1 ]
Gomez, Amalia [1 ]
Cruz, Juan J. [1 ]
机构：
[1] Hosp Univ Salamanca IBSAL, Dept Med Oncol, Salamanca, Spain
来源：
BREAST JOURNAL | 2017年 / 23卷 / 06期
关键词：
bevacizumab; breast cancer; nasal septum perforation; SEPTUM PERFORATION; PACLITAXEL; THERAPY; TRIAL;
D O I：
10.1111/tbj.12913
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Nasal septum perforation in patients with cancer receiving systemic therapy is rare, and its association with bevacizumab use has described recently in the literature. Here, we report the case of a 34-year-old woman with hormone-sensitive, HER-2/neu negative, metastatic breast cancer who develope a nasal septum perforation during the treatment with paclitaxel and bevacizumab.
引用
收藏
页码：745 / 746
页数：2
相关论文
共 50 条
  • [31] Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival
    Tadeu Ferreira Paiva
    Victor Hugo Fonseca de Jesus
    Raul Amorim Marques
    Alexandre André Balieiro Anastácio da Costa
    Mariana Petaccia de Macedo
    Patricia Maria Peresi
    Aline Damascena
    Benedito Mauro Rossi
    Maria Dirlei Begnami
    Vladmir Cláudio Cordeiro de Lima
    BMC Cancer, 15
  • [32] Intestinal perforation: an unusual adverse event of bevacizumab and paclitaxel combined therapy for a metastatic breast cancer
    Mychaluk, Johanna
    Piprot, Christine
    Sevestre, Henri
    Merviel, Philippe
    Gondry, Jean
    Fauvet, Raffaele
    PRESSE MEDICALE, 2009, 38 (09): : 1370 - 1374
  • [33] CLINICAL OUTCOMES IN BEVACIZUMAB-TREATED PATIENTS WITH METASTATIC COLORECTAL CANCER: RESULTS FROM ARIES OBSERVATIONAL COHORT STUDY AND CONFIRMATION OF BRITE DATA ON BEVACIZUMAB BEYOND PROGRESSION
    Cohn, A.
    Bekaii-Saab, T.
    Bendell, J.
    Hurwitz, H.
    Kozloff, M.
    Roach, N.
    Tezcan, H.
    Feng, S.
    Sing, A.
    Grothey, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 11 - 11
  • [34] Bevacizumab in the treatment of metastatic breast cancer
    Schuetz, Florian
    Sohn, Christof
    Schneeweiss, Andreas
    BREAST CARE, 2007, 2 (02) : 82 - 88
  • [35] Bevacizumab (Avastin) for metastatic breast cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2008, 50 (1287): : 42 - 43
  • [36] Is there room for bevacizumab in metastatic breast cancer?
    Brufsky, Adam
    LANCET ONCOLOGY, 2016, 17 (09): : 1175 - 1176
  • [37] Circulating epithelial tumor cells in patients with metastatic breast cancer treated with bevacizumab
    L Manso
    E Ciruelos
    A Rodríguez
    J Diaz
    C Mendiola
    JA López-Martín
    H Cortes-Funes
    Breast Cancer Research, 11
  • [38] Brain Necrosis in Patients With Metastatic Lung and Breast Cancer Successfully Treated With Bevacizumab
    Raez, L.
    Botero, A.
    Khan, A.
    Izquierdo, P.
    Castellon, I.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S241 - S241
  • [39] Circulating epithelial tumor cells in patients with metastatic breast cancer treated with bevacizumab
    Manso, L.
    Ciruelos, E.
    Rodriguez, A.
    Diaz, J.
    Mendiola, C.
    Lopez-Martin, J. A.
    Cortes-Funes, H.
    BREAST CANCER RESEARCH, 2009, 11 : S18 - S18
  • [40] Perirenal hematoma in a patient treated with bevacizumab for metastatic colon cancer: A case report
    Lee, Min Sung
    Shin, Il Sang
    Kwun, Do Hyung
    Kim, Se Hyung
    Kim, Hyun Jung
    Kim, Chan Kyu
    Park, Seong Kyu
    Hong, Dae Sik
    Yun, Jina
    ONCOLOGY LETTERS, 2016, 11 (05) : 3210 - 3212
12345